Drreddys Laboratories reported $25.7B in Gross Profit on Sales for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Ani Pharmaceuticals ANIP:US $ 27.65M 1.34M
Aphria Inc APH:CN C$ -7278000 20.68M
Aurora Cannabis Inc ACB:CN 14.1M 75.17M
Bayer BAYN:GR 5.89B 414M
Canopy Growth Corp WEED:CN C$ -71140000 98.38M
Catalent CTLT:US $ 324M 115.3M
Cipla CIPLA:IN 33.83B 524M
Corcept Therapeutics CORT:US $ 94.86M 4.65M
Endo International Ordinary Shares ENDP:US $ 474.91M 74.51M
GlaxoSmithKline GSK:LN 6.26B 682M
Gw Pharmaceuticals GWPH:US $ 140.66M 2.86M
Hikma Pharmaceutical HIK:LN 616M 5M
Horizon Pharma HZNP:US $ 785.35M 153.8M
JAZZ PHA JAZZ:US $ 692.89M 60.27M
Lannett LCI:US $ 16.52M 6.14M
Lonza Group LONN:SW 1.04B 418M
Novartis NOVN:VX 9.52B 21M
Pacira Pharmaceuticals PCRX:US $ 93.07M 7.27M
Phibro Animal Health PAHC:US $ 64.68M 5.15M
Prestige Brands PBH:US $ 157.71M 1.3M
Richter Gedeon RICHT:HB 85.72B 2.52B
Sun Pharmaceuticals SUNP:IN IR 71040.7M 347.6M
Supernus Pharmaceuticals SUPN:US $ 130.38M 14.08M
Teva Pharmaceutical TEVA:IT 1.9B 25M